Last reviewed · How we verify
NCT06713967
Comparison of Pregnancy Outcomes in Women with Polycystic Ovarian Syndrome with and Without Glucophage
NA trial testing Metformin (Glucophage) in Polycystic Ovarian Syndrome (PCOS) in 70 participants. Not yet recruiting.
25 May 2025
Quick facts
| Lead sponsor | University of Health Sciences Lahore |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 2 February 2025 |
| Primary completion | 25 May 2025 |
| Estimated completion | 26 May 2025 |
Drugs / interventions tested
- Metformin (Glucophage) — full drug profile →
- Standard Care (Diet and Exercise Only)
Conditions studied
- Polycystic Ovarian Syndrome (PCOS) — all drugs for Polycystic Ovarian Syndrome (PCOS) →
- Pregnancy Outcomes — all drugs for Pregnancy Outcomes →
Sponsor
University of Health Sciences Lahore
Who can join
Adults 18 to 40, female only, with Polycystic Ovarian Syndrome (PCOS) or Pregnancy Outcomes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if Glucophage (metformin) improves pregnancy outcomes in women with polycystic ovarian syndrome (PCOS). It will also evaluate the safety of Glucophage during pregnancy. The main questions it aims to answer are: Does Glucophage reduce the risks of early pregnancy loss, preterm delivery, and gestational diabetes? Are there any medical problems associated with taking Glucophage during pregnancy? Researchers will compare Glucophage with standard care (diet and exercise) to see if it improves pregnancy outcomes in women with PCOS. Participants will: Take Glucophage or follow a standard diet and exercise plan throughout pregnancy. Attend regular follow-up visits for checkups, ultrasounds, and blood tests. Have their pregnancy outcomes, such as fetal growth and gestational diabetes, recorded.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06713967
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Polycystic Ovarian Syndrome (PCOS)
Currently open trials in the same condition.
- NCT07392476 — Continuous Glucose Monitoring in Polycystic Ovarian Syndrome · active not recruiting
- NCT07157371 — Effects of Aerobic Exercise Training Program in Females With Insulin Resistant Polycystic Ovarian Syndrome · NA · active not recruiting
- NCT07399535 — Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome · Phase 1 · recruiting
Other University of Health Sciences Lahore trials
Trials by the same sponsor.
- NCT07484178 — Effectiveness of Nurse-Led Interventions on Respiratory Outcomes in Hospitalized Patients With Acute Exacerbation of Chr · NA · not yet recruiting
- NCT07526623 — Combined Effect of Benson Relaxation Technique and Jacobson Progressive Muscle Relaxation Exercises on Premenstrual Synd · NA · active not recruiting
- NCT07467070 — Effectiveness of Pilates on Postural Correction, Core Strength and Flexibility in Younger Individuals With Non-specific · NA · recruiting
- NCT07467044 — Combined Effects of Dead Bug Exercise and Double Straight Leg Raises Versus Conventional Physical Therapy Exercise on Co · NA · active not recruiting
- NCT07438834 — Continuous Sedation vs Daily Sedation Interruption in Ventilated Children · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06713967 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Health Sciences Lahore
- Last refreshed: 6 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06713967.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing